Method for predicting the fertility potential of a female subject
US-2024094221-A1 · Mar 21, 2024 · US
Stabilization of FSH
US8993732B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993732-B2 |
| Application number | US-201113704771-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 28, 2011 |
| Priority date | Jul 30, 2010 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention, pertains in general to the field of stabilization of FSH formulations, in particular liquid FSH formulations. The stabilization is achieved by the addition of salts comprising pharmaceutically acceptable alkali metal cations, in preferred embodiments by the addition of pharmaceutically acceptable salts, i.e. sodium salts or potassium salts.
First claim
Opening claim text (preview).
The invention claimed is: 1. A liquid FSH formulation comprising: follicle stimulating hormone (FSH); one or more preservatives; and sodium sulfate in an amount that stabilizes the FSH. 2. The liquid FSH formulation according to claim 1 , further comprising sodium chloride. 3. The liquid FSH formulation according to claim 1 , wherein the sodium sulfate is present in the liquid formulation at a concentration in the range from about 20…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
- A61K38/24Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8993732B2 cover?
- The present invention, pertains in general to the field of stabilization of FSH formulations, in particular liquid FSH formulations. The stabilization is achieved by the addition of salts comprising pharmaceutically acceptable alkali metal cations, in preferred embodiments by the addition of pharmaceutically acceptable salts, i.e. sodium salts or potassium salts.
- Who is the assignee on this patent?
- Sjögren Helen Ulrika, Bagger Heidi Louise, Ferring Bv
- What technology area does this patent fall under?
- Primary CPC classification A61K38/24. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).